Bank Julius Baer & Co. Ltd, Zurich Black Diamond Therapeutics, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$5.18 - $8.48 $155,400 - $254,400	-30,000 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$8.46 - $12.42 $257,683 - $378,300	-30,459 Reduced 50.38%	30,000 $254,000
Q2 2021 Jul 23, 2021	BUY	$12.19 - $28.17 $310,345 - $717,180	25,459 Added 72.74%	60,459 $737,000
Q1 2021 May 10, 2021	BUY	$22.23 - $34.75 $778,050 - $1.22 Million	35,000 New	35,000 $849,000

117

48.8M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $90.5M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.